Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Franco-Mateos E, Souza-Egipsy V, García-Estévez L, Pérez-García J, Gion M, Garrigós L, Cortez P, Saavedra C, Gómez P, Ortiz C, Cruz VL, Ramos J, Cortés J, Vega JF.
Franco-Mateos E, et al. Among authors: cortes j.
Int J Mol Sci. 2024 Apr 1;25(7):3940. doi: 10.3390/ijms25073940.
Int J Mol Sci. 2024.
PMID: 38612751
Free PMC article.